Lp-PLA(2) Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 In The Renal At Type 2 Diabetes Mellitus

PURPOSE: The aim of this study is to prove that type 2 diabetes mellitus can induce increasing inflammation marker in renal and that the provision of darapladib as Lp-LA2 Inhibitor agents can inhibit inflammation that were measured from the expression of IL-1B and IL-6- type cytokine in renal. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Wihastuti, Titin Andri, Aini, Fitria Nugraha, Tjahjono, Cholid Tri, Sulfia, Yuni Hendrati, Sholichah, Zuhrotus, Heriansyah, Teuku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830380/
https://www.ncbi.nlm.nih.gov/pubmed/31802883
http://dx.doi.org/10.2147/VHRM.S217904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830380/
https://www.ncbi.nlm.nih.gov/pubmed/31802883
http://dx.doi.org/10.2147/VHRM.S217904

Ejemplares similares